临床肺科杂志
臨床肺科雜誌
림상폐과잡지
JOUNAL OF CLINICAL PULMONARY MEDICINE
2015年
4期
592-595
,共4页
刘荣梅%王玉清%高孟秋%王玲%马丽萍
劉榮梅%王玉清%高孟鞦%王玲%馬麗萍
류영매%왕옥청%고맹추%왕령%마려평
结核病%耐多药结核病%危险因素
結覈病%耐多藥結覈病%危險因素
결핵병%내다약결핵병%위험인소
tuberculosis%multi-drug resistant tuberculosis%risk factors
目的:探讨导致耐多药肺结核病的危险因素,从而为预防和控制耐多药结核病提供依据。方法采用非匹配病例对照研究的方法,以青海省第四人民医院2013年1月-2014年6月的住院肺结核患者为样本框,痰罗氏培养结果为结核分枝杆菌复合群,药敏试验证实异烟肼和利福平同时耐药的患者为病例组;异烟肼和利福平均敏感的患者为对照组。对患者的姓名、年龄、性别、民族、婚姻状况、职业、住房、吸烟史、饮酒、既往治疗是否规律、病例分类(为初治或复治患者)、病变累及肺野数、肺内空洞数、病程、住房通风情况等相关因素做统计分析。结果采取logistic回归方法进行分析,最终耐多药肺结核发生的主要危险因素为复治病人患耐药的风险是初治的5.24倍,95%CI(2.005-14.648);病变范围>3个肺野数的患者患耐药的风险是≤3个肺野的0.177倍,95% CI(0.062-0.506);空洞数每上升一个等级,患耐药的风险是原来的7.686倍,95%CI(4.524-13.058)。结论加强对肺结核病例的管理,良好的治疗策略,做好基础DOTS工作,积极发现和治愈初复治结核病人,并针对其他危险因素采取措施对降低耐多药结核病疫情有重要意义。
目的:探討導緻耐多藥肺結覈病的危險因素,從而為預防和控製耐多藥結覈病提供依據。方法採用非匹配病例對照研究的方法,以青海省第四人民醫院2013年1月-2014年6月的住院肺結覈患者為樣本框,痰囉氏培養結果為結覈分枝桿菌複閤群,藥敏試驗證實異煙肼和利福平同時耐藥的患者為病例組;異煙肼和利福平均敏感的患者為對照組。對患者的姓名、年齡、性彆、民族、婚姻狀況、職業、住房、吸煙史、飲酒、既往治療是否規律、病例分類(為初治或複治患者)、病變纍及肺野數、肺內空洞數、病程、住房通風情況等相關因素做統計分析。結果採取logistic迴歸方法進行分析,最終耐多藥肺結覈髮生的主要危險因素為複治病人患耐藥的風險是初治的5.24倍,95%CI(2.005-14.648);病變範圍>3箇肺野數的患者患耐藥的風險是≤3箇肺野的0.177倍,95% CI(0.062-0.506);空洞數每上升一箇等級,患耐藥的風險是原來的7.686倍,95%CI(4.524-13.058)。結論加彊對肺結覈病例的管理,良好的治療策略,做好基礎DOTS工作,積極髮現和治愈初複治結覈病人,併針對其他危險因素採取措施對降低耐多藥結覈病疫情有重要意義。
목적:탐토도치내다약폐결핵병적위험인소,종이위예방화공제내다약결핵병제공의거。방법채용비필배병례대조연구적방법,이청해성제사인민의원2013년1월-2014년6월적주원폐결핵환자위양본광,담라씨배양결과위결핵분지간균복합군,약민시험증실이연정화리복평동시내약적환자위병례조;이연정화리복평균민감적환자위대조조。대환자적성명、년령、성별、민족、혼인상황、직업、주방、흡연사、음주、기왕치료시부규률、병례분류(위초치혹복치환자)、병변루급폐야수、폐내공동수、병정、주방통풍정황등상관인소주통계분석。결과채취logistic회귀방법진행분석,최종내다약폐결핵발생적주요위험인소위복치병인환내약적풍험시초치적5.24배,95%CI(2.005-14.648);병변범위>3개폐야수적환자환내약적풍험시≤3개폐야적0.177배,95% CI(0.062-0.506);공동수매상승일개등급,환내약적풍험시원래적7.686배,95%CI(4.524-13.058)。결론가강대폐결핵병례적관리,량호적치료책략,주호기출DOTS공작,적겁발현화치유초복치결핵병인,병침대기타위험인소채취조시대강저내다약결핵병역정유중요의의。
Objective To explore the risk factors of multi-drug resistant tuberculosis ( MDR-TB) , in order to provide the basis for the prevention and control of MDR-TB. Methods Non-matching case-control study was car-ried out in Qinghai. This study took patients in the Fourth People′s Hospital of Qinghai from January, 2013 to June, 2014 as match box. The results of sputum culture were mycobacterium tuberculosis complex. Those patients showing resistance to isoniazid and rifampicin were taken as the case group, and those showing sensitivity to isoniazid and rifampicin as the control group. The related factors were analyzed, including name, age, gender, nation, marital status, occupation, housing, history of smoking and drinking, regularity of treatment, case classification (initial or recurrent patients), existence of cavities of lung, scale of lesion on lung field, course of disease and housing ventilation. Results All of the factors were analyzed by logistic regression, and the risk factors causing multi-drug resistance included 5. 24 times 95%CI (2. 005-14. 648), extent of disease more than 3 lung fields, and more cavities. Conclusion The situation of MDR-TB can be controlled by strengthening the management of tuberculosis cases, taking sound treatment strategy, doing a good job in basic DOTS, early detection and treatment of the disease, and taking appropriate preventive measures to control other risk factors.